BRIEF-Anavex Life Sciences Announces Acceptance Of Peer-Reviewed Manuscript

Reuters
25 Nov 2024
BRIEF-Anavex Life Sciences Announces Acceptance Of Peer-Reviewed Manuscript

Nov 25 (Reuters) - Anavex Life Sciences Corp AVXL.O:

  • ANAVEX LIFE SCIENCES ANNOUNCES ACCEPTANCE OF PEER-REVIEWED MANUSCRIPT OF ORAL BLARCAMESINE PHASE IIB/III DATA IN A REFERENCE ALZHEIMER’S DISEASE JOURNAL

Source text: ID:nGNX8CVmg0

Further company coverage: AVXL.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10